Search Results 481-490 of 19466 for B cell lymphomas

  1. Pembrolizumab (intravenous route) - Side effects & uses - Mayo Clinic

    Pembrolizumab injection is used to treat primary mediastinal large B-cell lymphoma (PMBCL) in patients who have tried a treatment that did not work, or whose ...

  2. Study of Tipifarnib in Subjects With Relapsed or Refractory Peripheral T-Cell Lymphoma - Mayo Clinic

    ... Cell Lymphoma (PTCL). The total number of ... T-cell prolymphocytic leukemia; ... Known infection with HIV, or an active infection with hepatitis B or hepatitis C.

  3. A Phase 1b/2 Safety and Tolerability of MEDI6469 in Combination With Therapeutic Immune Agents or Monoclonal Antibodies - Mayo Clinic

    ... B-cell lymphoma (DLBCL). Tremelimumab and MEDI4736 will be tested with MEDI6469 in a set of subjects with advanced solid tumors while rituximab will be ...

  4. Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma - Mayo Clinic

    Bortezomib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Lenalidomide may stop the growth of mantle cell lymphoma ...

  5. A Study to Evaluate the Effectiveness and Safety of P276-00 for Mantle Cell Lymphoma that has Returned and/or is Resistant to Treatment - Mayo Clinic

    The purpose of this study is to determine whether P276-00 is safe and effective for the treatment of Mantle Cell Lymphoma that has returned or is not responding ...

  6. Cancer Physicians - Medical Professionals - Mayo Clinic

    Bone marrow transplant, Brain lymphoma, Lymphoma, Chronic lymphocytic leukemia, B-cell lymphoma. Pagination Physicians. PrevPrevious Page · Go to page 11 · Go ...

  7. A Study of JNJ-68284528, a Therapy Directed Against B-Cell Maturation Antigen (BCMA) in Participants with Relapsed or Refractory Multiple Myeloma - Mayo Clinic

    A Study of JNJ-68284528, a Therapy Directed Against B-Cell Maturation Antigen (BCMA) in Participants with Relapsed or Refractory Multiple Myeloma · Share ...

  8. Mayo Clinic Minute: What is CAR-T cell therapy?

    CAR-T cell therapy is a personalized and innovative treatment giving hope to patients diagnosed with various lymphomas. Learn more.

  9. Ernesto Ayala, M.D. - Doctors and Medical Staff - Mayo Clinic

    B-cell lymphoma · Burkitt lymphoma · Follicular lymphoma; Graft versus host disease; Hodgkin lymphoma; Non-Hodgkin lymphoma; T-cell lymphoma · Procedures ...

  10. Unleashing viruses aimed at killing cancer - Mayo Clinic News Network

    It has shown great promise by putting some B-cell lymphomas and leukemias into remission. CAR-T cells are highly targeted to tumor cells, with the goal of ...